Intestinal dysbiosis and inflammation in cystic fibrosis impacts gut and multi-organ axes
Cystic fibrosis (CF) is a multisystem genetic disease which affects numerous organs in the body. Patients with CF exhibit profound alterations in the gastrointestinal microbiome, characterised by an increase in pathogenic bacteria and reduction in beneficial commensal species, accompanied by intesti...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-09-01
|
| Series: | Medicine in Microecology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2590097822000076 |
| _version_ | 1811230807543513088 |
|---|---|
| author | Hannah E. Wrigley-Carr Josie M. van Dorst Chee Y. Ooi |
| author_facet | Hannah E. Wrigley-Carr Josie M. van Dorst Chee Y. Ooi |
| author_sort | Hannah E. Wrigley-Carr |
| collection | DOAJ |
| description | Cystic fibrosis (CF) is a multisystem genetic disease which affects numerous organs in the body. Patients with CF exhibit profound alterations in the gastrointestinal microbiome, characterised by an increase in pathogenic bacteria and reduction in beneficial commensal species, accompanied by intestinal inflammation. The proposed pathophysiology of these gastrointestinal changes is multifactorial, driven primarily by dysfunction of the CF transmembrane conductance regulator (CFTR) protein, and secondarily by medications and the high-fat CF diet. Increasingly, the gastrointestinal microbiome is being recognised as an endocrine-like organ which regulates the function of multiple organs via direct transmission of microbes and metabolites, inflammatory pathways, immunological crosstalk, and other mechanisms. This article aims to review how the gut microbiome in CF may influence other affected organs, including the intestines, lungs (gut-lung axis), liver (gut-liver axis), bones (gut-bone axis), pancreas (gut-pancreas axis), and brain (gut-brain axis). Further research is required to better understand the potential role of the gut microbiome in CF multisystem disease, and the therapeutic utility of gut and multi-organ axes in CF. |
| first_indexed | 2024-04-12T10:35:14Z |
| format | Article |
| id | doaj.art-d53ee5eb4158482d8320cebdf2208c13 |
| institution | Directory Open Access Journal |
| issn | 2590-0978 |
| language | English |
| last_indexed | 2024-04-12T10:35:14Z |
| publishDate | 2022-09-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Medicine in Microecology |
| spelling | doaj.art-d53ee5eb4158482d8320cebdf2208c132022-12-22T03:36:45ZengElsevierMedicine in Microecology2590-09782022-09-0113100057Intestinal dysbiosis and inflammation in cystic fibrosis impacts gut and multi-organ axesHannah E. Wrigley-Carr0Josie M. van Dorst1Chee Y. Ooi2School of Clinical Medicine, Discipline of Paediatrics & Child Health, UNSW Medicine and Health, University of New South Wales, 2052, AustraliaSchool of Clinical Medicine, Discipline of Paediatrics & Child Health, UNSW Medicine and Health, University of New South Wales, 2052, AustraliaSchool of Clinical Medicine, Discipline of Paediatrics & Child Health, UNSW Medicine and Health, University of New South Wales, 2052, Australia; Department of Gastroenterology, Sydney Children's Hospital, High Street, Randwick, NSW, 2031, Australia; Corresponding author. Centre for Child Health Research and Innovation, Level 8, Bright Alliance Building, Cnr of Avoca and High Streets, Randwick, NSW, 2031, Australia.Cystic fibrosis (CF) is a multisystem genetic disease which affects numerous organs in the body. Patients with CF exhibit profound alterations in the gastrointestinal microbiome, characterised by an increase in pathogenic bacteria and reduction in beneficial commensal species, accompanied by intestinal inflammation. The proposed pathophysiology of these gastrointestinal changes is multifactorial, driven primarily by dysfunction of the CF transmembrane conductance regulator (CFTR) protein, and secondarily by medications and the high-fat CF diet. Increasingly, the gastrointestinal microbiome is being recognised as an endocrine-like organ which regulates the function of multiple organs via direct transmission of microbes and metabolites, inflammatory pathways, immunological crosstalk, and other mechanisms. This article aims to review how the gut microbiome in CF may influence other affected organs, including the intestines, lungs (gut-lung axis), liver (gut-liver axis), bones (gut-bone axis), pancreas (gut-pancreas axis), and brain (gut-brain axis). Further research is required to better understand the potential role of the gut microbiome in CF multisystem disease, and the therapeutic utility of gut and multi-organ axes in CF.http://www.sciencedirect.com/science/article/pii/S2590097822000076Cystic fibrosisDysbiosisInflammationGut microbiomeGut-organ axes |
| spellingShingle | Hannah E. Wrigley-Carr Josie M. van Dorst Chee Y. Ooi Intestinal dysbiosis and inflammation in cystic fibrosis impacts gut and multi-organ axes Medicine in Microecology Cystic fibrosis Dysbiosis Inflammation Gut microbiome Gut-organ axes |
| title | Intestinal dysbiosis and inflammation in cystic fibrosis impacts gut and multi-organ axes |
| title_full | Intestinal dysbiosis and inflammation in cystic fibrosis impacts gut and multi-organ axes |
| title_fullStr | Intestinal dysbiosis and inflammation in cystic fibrosis impacts gut and multi-organ axes |
| title_full_unstemmed | Intestinal dysbiosis and inflammation in cystic fibrosis impacts gut and multi-organ axes |
| title_short | Intestinal dysbiosis and inflammation in cystic fibrosis impacts gut and multi-organ axes |
| title_sort | intestinal dysbiosis and inflammation in cystic fibrosis impacts gut and multi organ axes |
| topic | Cystic fibrosis Dysbiosis Inflammation Gut microbiome Gut-organ axes |
| url | http://www.sciencedirect.com/science/article/pii/S2590097822000076 |
| work_keys_str_mv | AT hannahewrigleycarr intestinaldysbiosisandinflammationincysticfibrosisimpactsgutandmultiorganaxes AT josiemvandorst intestinaldysbiosisandinflammationincysticfibrosisimpactsgutandmultiorganaxes AT cheeyooi intestinaldysbiosisandinflammationincysticfibrosisimpactsgutandmultiorganaxes |